Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Smoldering Multiple Myeloma × Monatide (IMS 3015) × 1 year × Clear all

Sponsor

Conditions

Pathologic Complete Response 1 Neoplasm, Residual 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Lenalidomide 8 Dexamethasone 4 daratumumab 3 Calcium Dobesilate 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Cyclophosphamide 2 Curcumin 2 pomalidomide 1 poly ICLC 1 pembrolizumab 1 ixazomib 1 isatuximab 1 iberdomide 1 fludarabine phosphate 1 fludarabine 1 citarinostat 1 Watchful Waiting 1 Urination 1 Stem Cell Transplantation 1 Resistance Training 1 Propranolol 1 Probiotics 1 PVX-410 vaccine 1 Observation 1 Metformin 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡